AdaptHealth entered into an Asset Purchase Agreement to sell substantially all assets of its diabetes care business to RGH Enterprises, a subsidiary of Cardinal Health, for $235 million in cash, subject to a working capital adjustment. Closing is contingent on antitrust clearance and other customary conditions, including employee acceptance thresholds and completion of a separation plan. The agreement includes escrowed amounts for purchase price adjustments and indemnities, and features non-compete, non-solicit, and confidentiality covenants. AdaptHealth expects the divestiture to streamline its portfolio and refocus resources.
Agreement details:
- Agreement type: Asset purchase agreement for sale of diabetes care business assets
- Counterparty: RGH Enterprises
- Signed / Effective: Jul 19 2026 / same
- Duration / Termination: One-time transaction
- Reason: Divest diabetes business and refocus resources
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.